The interaction between alpha-synuclein and mitochondrial dysfunction in Parkinson's disease

Biophys Chem. 2023 Dec:303:107122. doi: 10.1016/j.bpc.2023.107122. Epub 2023 Oct 10.

Abstract

Parkinson's disease (PD) is an aging-associated neurodegenerative disorder with the hallmark of abnormal aggregates of alpha-synuclein (α-syn) in Lewy bodies (LBs) and Lewy neurites (LNs). Currently, pathogenic α-syn and mitochondrial dysfunction have been considered as prominent roles that give impetus to the PD onset. This review describes the α-syn pathology and mitochondrial alterations in PD, and focuses on how α-syn interacts with multiple aspects of mitochondrial homeostasis in the pathogenesis of PD.

Keywords: Alpha-synuclein; Mitochondrial dysfunction; Mitochondrial homeostasis; Parkinson's disease.

Publication types

  • Review
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Humans
  • Lewy Bodies / metabolism
  • Lewy Bodies / pathology
  • Mitochondria
  • Neurodegenerative Diseases* / metabolism
  • Parkinson Disease* / metabolism
  • alpha-Synuclein / metabolism

Substances

  • alpha-Synuclein